FDA approves expanded use of eculizumab for pediatric myasthenia gravis
HQ Team March 13, 2025: The U.S. Food and Drug Administration (FDA) has approved the expanded use of drug eculizumab (marketed as Soliris)
HQ Team March 13, 2025: The U.S. Food and Drug Administration (FDA) has approved the expanded use of drug eculizumab (marketed as Soliris)
HQ Team March 13, 2025: A study published in the Journal of the American Heart Association reveals that limiting TV viewing to no more than
HQ Team March 12, 2025: In a significant development for HIV prevention, Gilead Sciences has unveiled promising data from its Phase 1 study
HQ Team March 12, 2025: Swiss pharmaceutical giant Roche has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma to
HQ Team March 11, 2025: A recent World Air Quality Report 2024 by Swiss air quality technology company IQAir, has highlighted that 13
HQ Team March 11, 2025: A recent study conducted by the University of Eastern Finland and Kuopio University Hospital has shown that an
HQ Team March 10, 2025: A recent study published in The BMJ forecasts a significant rise in Parkinson’s disease cases globally, with projections
HQ Team March 10, 2025: Patient screening in primary care settings can detect up to 10% of cancers caused by genes. Easily available
HQ Team March 8, 2025: A study published in The Lancet by the Global Burden of Disease Study BMI Collaborators reveals alarming statistics